Brief: Codexis Finalizes Purchase Agreement With Crosswalk Therapeutics For Gene Therapy Assets
01/07/2024 21:12
July 1 (Reuters) - Codexis Inc CDXS.O :
* CODEXIS FINALIZES PURCHASE AGREEMENT WITH CROSSWALK
THERAPEUTICS
FOR GENE THERAPY ASSETS
* CODEXIS-ELIGIBLE TO RECEIVE FUTURE DEVELOPMENT,COMMERCIAL
MILESTONE PAYMENTS IN ADDITION TO LOW-TO-MID SINGLE-DIGIT
PERCENTAGE NET SALES-BASED ROYALTY
Source text for Eikon: ID:nGNXbRrb0d
Further company coverage: CDXS.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Codexis
See all newsCodexis, Inc. reports results for the quarter ended June 30 - Earnings Summary
Codexis Q2 net loss narrows, helped by lower operating expenses
Codexis, Inc. expected to post a loss of 14 cents a share - Earnings Preview
U.S. STOCKS ON THE MOVE-Tenet, SLB, Digital Realty
U.S. STOCKS ON THE MOVE-Booz Allen Hamilton, Sensient, Amkor